The development of atopic dermatitis is independent of immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse mode

Clinical and Experimental Allergy

Volumn 38, Issue 8, 2008, Pages 1367-1380

  Chen, L ^a   Overbergh, L ^b   Mathieu, C ^b   Chan, L S ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Animal model; Atopic dermatitis; CD40L; IgE; Lymphocyte

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; LYMPHOTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN BLOOD LEVEL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTES; BACTERIAL CAPSULES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOGLOBULIN E; IMMUNOPHENOTYPING; INTERLEUKIN-4; MAST CELLS; MICE; MICE, HAIRLESS; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 47649084082     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2008.02987.x     Document Type: Article

References (56)

1. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994 102 : 128 37.
2. Cooper KD, Stevens SR. T cells in atopic dermatitis. J Am Acad Dermatol 2001 45 (Suppl. 1) : S10 2.
3. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003 361 : 151 60.
4. Novak N, Bieber T. Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol 2003 112 : 252 62.
5. Schmid-Grendelmeier P, Simon D, Simon HU, Akdis CA, Wuthrich B. Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy 2001 56 : 841 9.
6. Matsuda H, Watanabe N, Geba GP. et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997 9 : 461 6.
7. Gutermuth J, Ollert M, Ring J, Behrendt H, Jakob T. Mouse models of atopic eczema critically evaluated. Int Arch Allergy Immunol 2004 135 : 262 76.
8. Yoo J, Omori M, Gyarmati D. et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 2005 202 : 541 9.
9. Chan LS, Robinson N, Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 2001 117 : 977 83.
10. Yoshimoto T, Mizutani H, Tsutsui H. et al. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol 2000 1 : 132 7.
11. Barton D, HogenEsch H, Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol 2000 30 : 2323 32.
12. Tsukuba T, Okamoto K, Okamoto Y. et al. Association of cathepsin E deficiency with development of atopic dermatitis. J Biochem (Tokyo) 2003 134 : 893 902.
13. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998 101 : 1614 22.
14. Dillon SR, Sprecher C, Hammond A. et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004 5 : 752 60.
15. Chen L, Martinez O, Venkataramani P, Lin SX, Prabhakar BS, Chan LS. Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis. Clin Exp Immunol 2005 139 : 189 201.
16. Chen L, Martinez O, Overbergh L, Mathieu C, Prabhakar BS, Chan LS. Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model. Clin Exp Immunol 2004 138 : 375 87.
17. Chen L, Lin SX, Overbergh L, Mathieu C, Chan LS. The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the upregulations of B cell activation molecules, proliferation, and surface and serum IgE. Clin Exp Immunol 2005 142 : 21 30.
18. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980 92 : 44 7.
19. Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994 94 : 870 6.
20. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996 98 : 225 31.
21. Zachary CB, Allen MH, MacDonald DM. In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol 1985 112 : 149 56.
22. Lugovic L, Lipozenocic J, Jakic-Razumovic J. Atopic dermatitis: immunophenotyping of inflammatory cells in skin lesions. Int J Dermatol 2001 40 : 489 94.
23. Leung DY, Boguniewicz M, Howell MD, Nomura I, Hamid QA. New insights into atopic dermatitis. J Clin Invest 2004 113 : 651 7.
24. Leung DY, Jain N, Leo HL. New concepts in the pathogenesis of atopic dermatitis. Curr Opin Immunol 2003 15 : 634 8.
25. Chen L, Lin SX, Agha-Majzoub R, Overbergh L, Mathieu C, Chan LS. CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14-IL-4-transgenic mouse model. Int Immunol 2006 18 : 1233 42.
26. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet 1998 351 : 1715 21.
27. Agha-Majzoub R, Becker RP, Schraufnagel DE, Chan LS. Angiogenesis: the major abnormality of the keratin-14 IL-4 transgenic mouse model of atopic dermatitis. Microcirculation 2005 12 : 455 76.
28. Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001 25 : 386 401.
29. Overbergh L, Giulietti A, Valckx D, Decallonne R, Bouillon R, Mathieu C. The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech 2003 14 : 33 43.
30. Maatta J, Majuri ML, Luukkonen R. et al. Characterization of oak and birch dust-induced expression of cytokines and chemokines in mouse macrophage RAW 264.7 cells. Toxicology 2005 215 : 25 36.
31. Lever WF, Schaumberg-Lever G. Histopathology of the skin, 6th Edn. Philadelphia, PA : J.B. Lippincott Company, 1983.
32. Leung DY, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983 71 (Part 1) : 47 56.
33. Reinhold U, Kukel S, Goeden B, Neumann U, Kreysel HW. Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clin Exp Immunol 1991 86 : 444 8.
34. Halpern M, Schwartz S. Regulation of the low affinity IgE Fc receptor (CD23) in atopic dermatitis. Int Arch Allergy Immunol 1993 100 : 197 200.
35. Hamamoto Y, Nagai K, Muto M, Asagami C. Inhibitory effect of azelastine, a potent antiallergic agent, on release of tumor necrosis factor-alpha from activated human peripheral blood mononuclear cells and U937 cells. Exp Dermatol 1993 2 : 231 5.
36. Grewe M, Gyufko K, Schopf E, Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994 343 : 25 6.
37. Davison S, Allen M, Vaughan R, Barker J. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive V beta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes. Clin Exp Immunol 2000 121 : 181 6.
38. Campbell DE, Kemp AS. Proliferation and production of interferon-gamma (IFN-gamma) and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood atopic dermatitis. Clin Exp Immunol 1997 107 : 392 7.
39. Yudate T, Yamada H, Tezuka T. Role of staphylococcal enterotoxins in pathogenesis of atopic dermatitis: growth and expression of T cell receptor V beta of peripheral blood mononuclear cells stimulated by enterotoxins A and B. J Dermatol Sci 1996 13 : 63 70.
40. Matsuoka H, Maki N, Yoshida S. et al. A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 2003 58 : 139 45.
41. Johansson SG, Bieber T, Dahl R. et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003. J Allergy Clin Immunol 2004 113 : 832 6.
42. Rho NK, Kim WS, Lee DY, Lee JH, Lee ES, Yang JM. Immunophenotyping of inflammatory cells in lesional skin of the extrinsic and intrinsic types of atopic dermatitis. Br J Dermatol 2004 151 : 119 25.
43. Akdis CA, Akdis M, Simon D. et al. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 1999 113 : 628 34.
44. Akdis CA, Akdis M, Simon D. et al. Role of T cells and cytokines in the intrinsic form of atopic dermatitis. Curr Probl Dermatol 1999 28 : 37 44.
45. Jeong CW, Ahn KS, Rho NK. et al. Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy 2003 33 : 1717 24.
46. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev 1997 77 : 1033 79.
47. Kinet JP. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 1999 17 : 931 72.
48. Ferry X, Brehin S, Kamel R, Landry Y. G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 2002 23 : 1507 15.
49. Simon D, Braathen LR, Simon HU. Anti-interleukin-5 antibody therapy in eosinophilic diseases. Pathobiology 2005 72 : 287 92.
50. Amerio P, Frezzolini A, Feliciani C. et al. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications. Curr Drug Targets Inflamm Allergy 2003 2 : 81 94.
51. Zimmermann N, Hogan SP, Mishra A. et al. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J Immunol 2000 165 : 5839 46.
52. Matsumoto M, Ra C, Kawamoto K. et al. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol 1999 162 : 1056 63.
53. Zhang R, Fichtenbaum CJ, Hildeman DA, Lifson JD, Chougnet C. CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription. J Immunol 2004 172 : 2678 86.
54. Cunningham AF, Serre K, Mohr E, Khan M, Toellner KM. Loss of CD154 impairs the Th2 extrafollicular plasma cell response but not early T cell proliferation and interleukin-4 induction. Immunology 2004 113 : 187 93.
55. Cron RQ, Bandyopadhyay R, Genin A. et al. Early growth response-1 is required for CD154 transcription. J Immunol 2006 176 : 811 8.
56. Novak N, Bieber T, Leung DY. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003 112 (Suppl. 6) : S128 39.